查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1493567

兽医辅助生殖技术市场 - 全球产业规模、份额、趋势、机会和预测，按产品、动物类型、受孕方法、配销通路区域和竞争细分，2019-2029F

Veterinary Assistive Reproduction Technology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Animal Type, By Conception Method, By Distribution Channel Region and Competition, 2019-2029F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2023年全球兽医辅助生殖技术市场估值为24.4亿美元，预计在预测期内将稳定成长，到2029年复合年增长率为7.08%。推动由几个关键因素决定。一个主要驱动因素是对优质牲畜和伴侣动物的需求不断增长，以及对遗传疾病和育种相​​关问题的认识不断增强。这种需求导致了人工授精、胚胎移植、体外受精以及精子和卵母细胞冷冻保存等辅助生殖技术的广泛采用。

市场概况
预测期 2025-2029
2023 年市场规模 24.4亿美元
2029 年市场规模 36.6亿美元
2024-2029 年复合年增长率 7.08%
成长最快的细分市场 正常精液
最大的市场 北美洲

这些技术应用于各种动物物种，包括牛、猪、马、狗、猫和外来物种，以提高育种效率、遗传多样性和繁殖结果。生物技术、基因组学和生殖生理学的进步进一步促进了创新生殖技术和诊断工具的发展，推动了市场的成长。

宠物拥有量的增加、对高价值动物产品的需求不断增长以及新兴经济体对动物保健基础设施的投资不断增加等因素正在推动市场扩张。兽医辅助生殖技术市场的公司正在大力投资研发活动，以推出新颖的产品和服务，扩大其产品组合，并增强其市场占有率。

策略合作、伙伴关係和收购也是市场参与者加强在竞争格局中立足点的普遍策略。该市场面临严格的监管要求、围绕动物生殖技术使用的伦理考虑以及与先进生殖程序相关的高成本等挑战。儘管存在这些挑战，技术的不断进步以及对动物福利和生产力的日益关注预计将维持市场的扩张轨迹。

市场上值得关注的主要趋势包括精准育种技术的采用、人工智慧和巨量资料分析在繁殖管理中的整合，以及针对特定动物育种目标和挑战的客製化繁殖解决方案的出现。由于动物育种和医疗保健领域对先进生殖解决方案的需求不断增长，全球兽医辅助生殖技术市场拥有广泛的成长机会。

主要市场驱动因素

对优质牲畜和伴侣动物的需求不断增长

生物技术和基因组学的进步

对遗传疾病和育种相​​关问题的认识不断提高

主要市场挑战

监管障碍和合规要求

道德议题和动物福利

先进生殖手术的高成本

主要市场趋势

人工智慧与大数据分析的融合

采用精准育种技术

细分市场洞察

动物类型见解

受孕方法见解

区域洞察

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：客户之声

第 5 章：全球兽医辅助生殖技术市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 副产品（正常精液、性控精液）
    • 依动物类型（牛、猪、绵羊、山羊、马、其他动物）
    • 依受孕方法（人工授精、胚胎移植（MOET）、IVF）
    • 按配销通路（私人、公共）
    • 按地区
    • 按公司划分 (2023)
  • 市场地图
    • 按产品分类
    • 依动物类型
    • 依受孕方法
    • 按配销通路
    • 按地区

第 6 章：亚太地区兽医辅助生殖技术市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品分类
    • 依动物类型
    • 依受孕方法
    • 按配销通路
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 澳洲
    • 日本
    • 韩国

第 7 章：欧洲兽医辅助生殖技术市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品分类
    • 依动物类型
    • 依受孕方法
    • 按配销通路
    • 按国家/地区
  • 欧洲：国家分析
    • 法国
    • 德国
    • 西班牙
    • 义大利
    • 英国

第 8 章：北美兽医辅助生殖技术市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品分类
    • 依动物类型
    • 依受孕方法
    • 按配销通路
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 墨西哥
    • 加拿大

第 9 章：南美洲兽医辅助生殖技术市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品分类
    • 依动物类型
    • 依受孕方法
    • 按配销通路
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第10章：中东和非洲兽医辅助生殖技术市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品分类
    • 依动物类型
    • 依受孕方法
    • 按配销通路
    • 按国家/地区
  • MEA：国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 埃及

第 11 章：市场动态

  • 司机
  • 挑战

第 12 章：市场趋势与发展

  • 最近的发展
  • 产品发布（如有）
  • 併购（如有）

第 13 章：全球兽医辅助生殖技术市场：SWOT 分析

第 14 章：波特的五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第15章：竞争格局

  • Genus Plc
  • URUS Group LP
  • CRV Holding BV
  • Semex Usa Inc
  • Select Sires, Inc.
  • Swine Genetics International Ltd.
  • Inguran Sorting Technologies LLP
  • Viking Genetics Fmba
  • Geno SA

第 16 章：策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 23844

Global Veterinary Assistive Reproduction Technology Market was valued at USD 2.44 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 7.08% through 2029. The global veterinary assistive reproduction technology market has experienced significant growth in recent years, driven by several key factors. One major driver is the increasing demand for high-quality livestock and companion animals, coupled with growing awareness about genetic diseases and breeding-related issues. This demand has led to the widespread adoption of assisted reproductive techniques such as artificial insemination, embryo transfer, in vitro fertilization, and sperm and oocyte cryopreservation.

Market Overview
Forecast Period2025-2029
Market Size 2023USD 2.44 Billion
Market Size 2029USD 3.66 Billion
CAGR 2024-20297.08%
Fastest Growing SegmentNormal Semen
Largest MarketNorth America

These techniques are employed across various animal species, including cattle, pigs, horses, dogs, cats, and exotic species, to improve breeding efficiency, genetic diversity, and reproductive outcomes. Advancements in biotechnology, genomics, and reproductive physiology have further contributed to the development of innovative reproductive technologies and diagnostic tools, fueling market growth.

Factors such as increasing pet ownership, rising demand for high-value animal products, and growing investments in animal healthcare infrastructure in emerging economies are driving market expansion. Companies in the veterinary assistive reproduction technology market are investing heavily in research and development activities to introduce novel products and services, expand their product portfolios, and enhance their market presence.

Strategic collaborations, partnerships, and acquisitions are also prevalent strategies among market players to strengthen their foothold in the competitive landscape. The market faces challenges such as stringent regulatory requirements, ethical considerations surrounding the use of reproductive technologies in animals, and the high cost associated with advanced reproductive procedures. Despite these challenges, ongoing advancements in technology and increasing focus on animal welfare and productivity are expected to sustain the market's expansion trajectory.

Key trends to watch in the market include the adoption of precision breeding techniques, the integration of artificial intelligence and big data analytics in reproductive management, and the emergence of customized reproductive solutions tailored to specific animal breeding objectives and challenges. The global veterinary assistive reproduction technology market holds promising growth opportunities, driven by the growing demand for advanced reproductive solutions in animal breeding and healthcare.

Key Market Drivers

Growing Demand for High-Quality Livestock and Companion Animals

The growing demand for high-quality livestock and companion animals is a significant driver behind the expansion of the global veterinary assistive reproduction technology market. As populations increase and dietary preferences shift towards higher-quality meat and animal products, there is a corresponding need for efficient and sustainable animal production systems. This demand extends to both livestock used in agriculture and companion animals kept as pets.

In the realm of agriculture, farmers and producers are increasingly turning to advanced reproductive technologies to enhance breeding efficiency and genetic diversity within their herds. Techniques such as artificial insemination, embryo transfer, and in vitro fertilization allow for the rapid propagation of superior genetic traits, such as disease resistance, meat quality, and reproductive performance. By utilizing these technologies, breeders can produce offspring with desirable characteristics more efficiently than traditional breeding methods, resulting in higher yields, improved animal welfare, and enhanced profitability.

In the realm of companion animals, pet owners are seeking ways to ensure the health, longevity, and genetic soundness of their beloved pets. This has led to a growing demand for reproductive services such as sperm and oocyte cryopreservation, assisted reproductive procedures, and genetic screening. Pet owners are increasingly willing to invest in these technologies to address infertility issues, prevent hereditary diseases, and preserve the genetic lineage of their pets. As the human-animal bond strengthens, pets are increasingly viewed as family members, further driving the demand for advanced reproductive solutions to ensure their well-being.

The globalization of the livestock trade and the rising demand for high-quality animal products in emerging economies have further fueled the need for advanced reproductive technologies. Countries seeking to enhance their agricultural productivity and food security are investing in modern breeding techniques to improve the performance and resilience of their livestock populations. This has created a growing market for veterinary assistive reproduction technology on a global scale, with opportunities for manufacturers, service providers, and research institutions to cater to the needs of diverse animal breeding industries worldwide.

Advancements in Biotechnology and Genomics

Advancements in biotechnology and genomics have been instrumental in driving the growth of the global veterinary assistive reproduction technology market. These technological innovations have revolutionized the field of veterinary reproductive medicine, offering new tools and techniques to enhance breeding outcomes and genetic management in animals. Biotechnology and genomics have enabled veterinarians and animal breeders to gain a deeper understanding of the genetic makeup and physiological processes underlying reproduction in animals. The mapping of animal genomes and the identification of genes associated with desirable traits such as disease resistance, productivity, and reproductive performance have provided valuable insights into the genetic potential of different species and breeds. This knowledge forms the foundation for the development of targeted breeding programs and the selection of superior breeding stock.

One of the key applications of biotechnology in veterinary reproduction is the development of assisted reproductive techniques (ARTs) that leverage advancements in molecular biology and reproductive physiology. Techniques such as in vitro fertilization (IVF), embryo transfer, and sperm and oocyte cryopreservation allow for the manipulation and preservation of genetic material with precision and efficiency. These ARTs enable breeders to overcome reproductive challenges such as infertility, low fertility rates, and genetic disorders, thereby improving breeding efficiency and genetic diversity within animal populations. Genomics has facilitated the integration of genetic information into breeding decisions through techniques such as marker-assisted selection (MAS) and genomic selection (GS). MAS allows breeders to identify and select animals with desired genetic traits based on the presence of specific genetic markers associated with those traits. GS, on the other hand, uses genomic data to predict the breeding value of animals more accurately, enabling breeders to make informed decisions about which animals to breed and which traits to prioritize.

The combination of biotechnology and genomics has also led to the development of novel diagnostic tools and genetic screening assays that enable the early detection of hereditary diseases and genetic abnormalities in animals. These tools empower breeders to implement preventive measures and breeding strategies to minimize the transmission of undesirable traits and improve overall herd health.

Rising Awareness of Genetic Diseases and Breeding-related Issues

The rising awareness of genetic diseases and breeding-related issues is a significant factor driving the growth of the global veterinary assistive reproduction technology market. As stakeholders in the animal industry become increasingly cognizant of the impact of genetic disorders on animal health and productivity, there is a growing demand for advanced reproductive solutions to mitigate these challenges. One of the primary drivers behind the increased awareness of genetic diseases is the recognition of their detrimental effects on animal welfare and economic productivity. Hereditary diseases and genetic abnormalities can lead to a range of health problems in animals, including developmental disorders, congenital defects, and susceptibility to infectious diseases. In agricultural settings, the presence of genetic diseases can result in reduced fertility rates, lower growth rates, and increased mortality rates, leading to significant economic losses for producers. Similarly, in the companion animal sector, genetic disorders can cause suffering and reduced quality of life for pets, as well as emotional and financial burdens for their owners.

Advances in veterinary diagnostics and genetic testing have contributed to the heightened awareness of genetic diseases and breeding-related issues. Veterinarians and breeders now have access to a wide range of diagnostic tools and genetic screening assays that enable them to identify and characterize genetic disorders in animals more accurately and efficiently. These tools empower stakeholders to make informed breeding decisions, implement preventive measures, and develop targeted breeding strategies to reduce the incidence of hereditary diseases in animal populations. The preservation of genetic diversity and the conservation of rare and endangered breeds have become increasingly important considerations in animal breeding and conservation efforts. As stakeholders recognize the value of genetic diversity in maintaining the health and resilience of animal populations, there is a growing demand for reproductive technologies that facilitate genetic preservation and diversity management. Techniques such as sperm and oocyte cryopreservation, embryo banking, and assisted reproductive procedures enable breeders to safeguard valuable genetic resources, prevent the loss of genetic diversity, and contribute to the long-term sustainability of animal agriculture and biodiversity conservation.

Key Market Challenges

Regulatory Hurdles and Compliance Requirements

One of the primary challenges facing the veterinary assistive reproduction technology market is navigating regulatory hurdles and compliance requirements. Different countries have varying regulations governing the use of reproductive technologies in animals, including licensing, safety standards, and ethical considerations. The complex regulatory landscape can create barriers to market entry for manufacturers and service providers, leading to delays in product approvals and increased compliance costs. Moreover, inconsistencies in regulatory frameworks across regions can hinder international trade and collaboration, limiting market growth opportunities.

Ethical Concerns and Animal Welfare

Ethical concerns surrounding the use of reproductive technologies in animals present significant challenges to the veterinary assistive reproduction technology market. Some stakeholders raise ethical objections to certain assisted reproductive procedures, citing concerns about animal welfare, genetic manipulation, and the commodification of living organisms. Issues such as embryo manipulation, surrogate pregnancy, and the use of genetically modified organisms (GMOs) in breeding programs can provoke public debate and regulatory scrutiny, potentially affecting market acceptance and adoption. Addressing ethical considerations and ensuring the welfare of animals involved in reproductive procedures are essential for fostering trust and acceptance among consumers and stakeholders.

High Cost of Advanced Reproductive Procedures

The high cost associated with advanced reproductive procedures poses a significant challenge to the widespread adoption of veterinary assistive reproduction technology. Techniques such as in vitro fertilization, embryo transfer, and genetic screening require specialized equipment, facilities, and expertise, making them costly to implement and maintain. Additionally, factors such as the need for skilled personnel, laboratory supplies, and quality control measures further contribute to the overall expense of assisted reproductive services. For animal breeders, producers, and pet owners, the prohibitive cost of advanced reproductive procedures can act as a barrier to accessing these technologies, limiting market growth and adoption rates.

Key Market Trends

Integration of Artificial Intelligence and Big Data Analytics

One of the key ways in which AI and big data analytics are driving market growth is through the optimization of breeding outcomes and reproductive efficiency. By analyzing large datasets of genetic, physiological, and environmental factors, AI algorithms and machine learning techniques can identify trends, patterns, and correlations that may not be apparent to human observers. This enables veterinarians and breeders to make more informed breeding decisions, predict reproductive performance, and optimize breeding strategies to improve animal health and productivity.

AI and big data analytics are revolutionizing the field of reproductive genetics by enabling the identification of genetic markers associated with desirable traits. Through techniques such as genomic selection (GS) and marker-assisted selection (MAS), breeders can prioritize animals with favorable genetic profiles and accelerate genetic improvement programs. This not only enhances the overall genetic quality of animal populations but also helps to reduce the incidence of hereditary diseases and improve the resilience of livestock and companion animals. The integration of AI and big data analytics is driving innovation in assisted reproductive technologies, such as in vitro fertilization (IVF), embryo transfer, and sperm and oocyte cryopreservation. By analyzing vast amounts of reproductive data, AI algorithms can optimize the timing and conditions of assisted reproductive procedures to maximize success rates and minimize costs. This has the potential to revolutionize the delivery of reproductive services and make advanced reproductive technologies more accessible and affordable to a wider range of breeders, producers, and pet owners.

Also, AI and big data analytics are enabling the development of predictive models for reproductive management, disease detection, and fertility forecasting. By analyzing historical data and real-time inputs, AI algorithms can predict reproductive outcomes, identify potential health issues, and recommend preventive measures to mitigate risks. This proactive approach to reproductive management not only improves animal welfare but also helps to optimize resource allocation and minimize economic losses for animal producers and breeders.

Adoption of Precision Breeding Techniques

The adoption of precision breeding techniques is playing a pivotal role in driving the growth of the global veterinary assistive reproduction technology market. Precision breeding encompasses a range of advanced reproductive technologies and genetic management strategies aimed at achieving specific breeding objectives with unprecedented accuracy and efficiency. This trend is revolutionizing the field of veterinary reproductive medicine and offering new opportunities for improving animal health, productivity, and genetic diversity.

Precision breeding techniques leverage advancements in genomics, molecular biology, and assisted reproductive technologies to select animals with desirable traits and optimize breeding outcomes. Through techniques such as marker-assisted selection (MAS) and genomic selection (GS), breeders can identify and prioritize genetic markers associated with traits of interest, such as disease resistance, productivity, and temperament. By incorporating genetic information into breeding decisions, breeders can accelerate genetic improvement programs, reduce the incidence of hereditary diseases, and enhance the overall genetic quality of animal populations.

One of the key drivers behind the adoption of precision breeding techniques is the increasing demand for high-quality livestock and companion animals. With rising global populations and changing consumer preferences, there is growing pressure on animal producers and breeders to improve the efficiency and sustainability of animal production systems. Precision breeding offers a powerful tool for meeting these demands by enabling breeders to produce animals with superior traits more efficiently than traditional breeding methods.

Precision breeding techniques are also driving innovation and growth in the veterinary reproductive technology market by facilitating the development of customized reproductive solutions tailored to specific breeding objectives and challenges. Service providers are offering a wide range of personalized reproductive services, including genetic counseling, embryo selection, and customized breeding programs, to meet the unique needs of individual breeders, producers, and pet owners. This trend is enhancing customer satisfaction and driving demand for specialized reproductive services in the veterinary market.

Segmental Insights

Animal Type Insights

Based on the animal type, bovine segment emerged as the dominant segment in the global veterinary assistive reproduction technology market in 2023. The bovine industry represents a significant portion of the global agricultural economy, with dairy and beef production being major contributors to food supply chains worldwide. As such, there is a pressing need within the bovine sector for efficient reproductive technologies to optimize breeding outcomes, genetic diversity, and overall productivity. Veterinary assistive reproduction technologies offer solutions to address challenges such as low fertility rates, genetic disorders, and the need for genetic improvement programs.

Conception Method Insights

Based on the conception method, artificial insemination segment emerged as the dominant segment in the global veterinary assistive reproduction technology market in 2023. Advancements in AI technologies and techniques have expanded its applicability and efficacy in different animal species, including cattle, pigs, sheep, horses, and companion animals. Improved semen collection, processing, and storage methods, coupled with the development of synchronized estrus protocols and reproductive hormone treatments, have enhanced the success rates of AI procedures and widened its adoption in diverse breeding programs.

Regional Insights

North America established itself as the leading region in the global veterinary assistive reproduction technology market, commanding the largest market share. This dominance can be attributed to several key factors that distinguish the region's veterinary healthcare landscape.

North America boasts a highly developed veterinary healthcare infrastructure, characterized by a network of advanced veterinary clinics, research institutions, and biotechnology companies. These entities have access to state-of-the-art facilities and equipment, enabling them to offer a wide range of advanced reproductive services to animal owners and breeders.

North America benefits from a robust research and development ecosystem, with significant investments in scientific research and innovation. This ecosystem has facilitated the development and commercialization of cutting-edge reproductive technologies tailored to the specific needs of various animal species.

The region's proactive approach to regulatory frameworks and quality standards also contributes to its leadership position in the market. Stringent regulations ensure the safety, efficacy, and ethical use of reproductive technologies, instilling confidence among consumers and fostering market growth. North America's strong veterinary education and training programs ensure a skilled workforce capable of delivering high-quality reproductive services. This skilled workforce, combined with advanced infrastructure and innovative technologies, positions North America as a hub for veterinary assistive reproduction technology.

Key Market Players

Genus Plc

URUS Group LP

CRV Holding B.V.

Semex Usa Inc

Select Sires, Inc.

Swine Genetics International Ltd.

Inguran Sorting Technologies LLP

Viking Genetics Fmba

Geno SA

Report Scope:

In this report, the Global Veterinary Assistive Reproduction Technology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Assistive Reproduction Technology Market, By Product:

    Normal Semen Sexed Semen

Veterinary Assistive Reproduction Technology Market, By Animal Type:

    Bovine Swine Ovine Caprine Equine Other Animals

Veterinary Assistive Reproduction Technology Market, By Conception Method:

    Artificial Insemination Embryo transfer (MOET) IVF

Veterinary Assistive Reproduction Technology Market, By Distribution Channel:

    Private Public

Veterinary Assistive Reproduction Technology Market, By Region:

    North America

United States

Canada

Mexico

    Europe

France

United Kingdom

Italy

Germany

Spain

    Asia-Pacific

China

India

Japan

Australia

South Korea

    South America

Brazil

Argentina

Colombia

    Middle East & Africa

South Africa

Saudi Arabia

UAE

Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Assistive Reproduction Technology Market.

Available Customizations:

Global Veterinary Assistive Reproduction Technology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customers

5. Global Veterinary Assistive Reproduction Technology Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Normal Semen, Sexed Semen)
    • 5.2.2. By Animal Type (Bovine, Swine, Ovine, Caprine, Equine, Other Animals)
    • 5.2.3. By Conception Method (Artificial Insemination, Embryo transfer (MOET), IVF)
    • 5.2.4. By Distribution Channel (Private, Public)
    • 5.2.5. By Region
    • 5.2.6. By Company (2023)
  • 5.3. Market Map
    • 5.3.1. By Product
    • 5.3.2. By Animal Type
    • 5.3.3. By Conception Method
    • 5.3.4. By Distribution Channel
    • 5.3.5. By Region

6. Asia Pacific Veterinary Assistive Reproduction Technology Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Animal Type
    • 6.2.3. By Conception Method
    • 6.2.4. By Distribution Channel
    • 6.2.5. By Country
  • 6.3. Asia Pacific: Country Analysis
    • 6.3.1. China Veterinary Assistive Reproduction Technology Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Animal Type
        • 6.3.1.2.3. By Conception Method
        • 6.3.1.2.4. By Distribution Channel
    • 6.3.2. India Veterinary Assistive Reproduction Technology Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Animal Type
        • 6.3.2.2.3. By Conception Method
        • 6.3.2.2.4. By Distribution Channel
    • 6.3.3. Australia Veterinary Assistive Reproduction Technology Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Animal Type
        • 6.3.3.2.3. By Conception Method
        • 6.3.3.2.4. By Distribution Channel
    • 6.3.4. Japan Veterinary Assistive Reproduction Technology Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Product
        • 6.3.4.2.2. By Animal Type
        • 6.3.4.2.3. By Conception Method
        • 6.3.4.2.4. By Distribution Channel
    • 6.3.5. South Korea Veterinary Assistive Reproduction Technology Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Product
        • 6.3.5.2.2. By Animal Type
        • 6.3.5.2.3. By Conception Method
        • 6.3.5.2.4. By Distribution Channel

7. Europe Veterinary Assistive Reproduction Technology Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Animal Type
    • 7.2.3. By Conception Method
    • 7.2.4. By Distribution Channel
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Veterinary Assistive Reproduction Technology Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Animal Type
        • 7.3.1.2.3. By Conception Method
        • 7.3.1.2.4. By Distribution Channel
    • 7.3.2. Germany Veterinary Assistive Reproduction Technology Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Animal Type
        • 7.3.2.2.3. By Conception Method
        • 7.3.2.2.4. By Distribution Channel
    • 7.3.3. Spain Veterinary Assistive Reproduction Technology Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Animal Type
        • 7.3.3.2.3. By Conception Method
        • 7.3.3.2.4. By Distribution Channel
    • 7.3.4. Italy Veterinary Assistive Reproduction Technology Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Animal Type
        • 7.3.4.2.3. By Conception Method
        • 7.3.4.2.4. By Distribution Channel
    • 7.3.5. United Kingdom Veterinary Assistive Reproduction Technology Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Animal Type
        • 7.3.5.2.3. By Conception Method
        • 7.3.5.2.4. By Distribution Channel

8. North America Veterinary Assistive Reproduction Technology Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Animal Type
    • 8.2.3. By Conception Method
    • 8.2.4. By Distribution Channel
    • 8.2.5. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Veterinary Assistive Reproduction Technology Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Animal Type
        • 8.3.1.2.3. By Conception Method
        • 8.3.1.2.4. By Distribution Channel
    • 8.3.2. Mexico Veterinary Assistive Reproduction Technology Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Animal Type
        • 8.3.2.2.3. By Conception Method
        • 8.3.2.2.4. By Distribution Channel
    • 8.3.3. Canada Veterinary Assistive Reproduction Technology Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Animal Type
        • 8.3.3.2.3. By Conception Method
        • 8.3.3.2.4. By Distribution Channel

9. South America Veterinary Assistive Reproduction Technology Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Animal Type
    • 9.2.3. By Conception Method
    • 9.2.4. By Distribution Channel
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Veterinary Assistive Reproduction Technology Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Animal Type
        • 9.3.1.2.3. By Conception Method
        • 9.3.1.2.4. By Distribution Channel
    • 9.3.2. Argentina Veterinary Assistive Reproduction Technology Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Animal Type
        • 9.3.2.2.3. By Conception Method
        • 9.3.2.2.4. By Distribution Channel
    • 9.3.3. Colombia Veterinary Assistive Reproduction Technology Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Animal Type
        • 9.3.3.2.3. By Conception Method
        • 9.3.3.2.4. By Distribution Channel

10. Middle East and Africa Veterinary Assistive Reproduction Technology Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Animal Type
    • 10.2.3. By Conception Method
    • 10.2.4. By Distribution Channel
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Veterinary Assistive Reproduction Technology Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Animal Type
        • 10.3.1.2.3. By Conception Method
        • 10.3.1.2.4. By Distribution Channel
    • 10.3.2. Saudi Arabia Veterinary Assistive Reproduction Technology Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Animal Type
        • 10.3.2.2.3. By Conception Method
        • 10.3.2.2.4. By Distribution Channel
    • 10.3.3. UAE Veterinary Assistive Reproduction Technology Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Animal Type
        • 10.3.3.2.3. By Conception Method
        • 10.3.3.2.4. By Distribution Channel
    • 10.3.4. Egypt Veterinary Assistive Reproduction Technology Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Product
        • 10.3.4.2.2. By Animal Type
        • 10.3.4.2.3. By Conception Method
        • 10.3.4.2.4. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches (If Any)
  • 12.3. Mergers & Acquisitions (If Any)

13. Global Veterinary Assistive Reproduction Technology Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. Competitive Landscape

  • 15.1. Genus Plc
    • 15.1.1. Business overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. URUS Group LP
  • 15.3. CRV Holding B.V
  • 15.4. Semex Usa Inc
  • 15.5. Select Sires, Inc.
  • 15.6. Swine Genetics International Ltd.
  • 15.7. Inguran Sorting Technologies LLP
  • 15.8. Viking Genetics Fmba
  • 15.9. Geno SA

16. Strategic Recommendations

17. About Us & Disclaimer